![]() |
Volumn 74, Issue 5, 2006, Pages 414-418
|
Pharmacokinetics and safety of tanaproget, a nonsteroidal progesterone receptor agonist, in healthy women
|
Author keywords
Oral contraceptive; Pharmacokinetics; Progesterone receptor agonist; Tanaproget
|
Indexed keywords
CONTRACEPTIVE AGENT;
PLACEBO;
PROGESTERONE RECEPTOR AGONIST;
TANAPROGET;
UNCLASSIFIED DRUG;
ABDOMINAL CRAMP;
ABDOMINAL PAIN;
ADULT;
ARTICLE;
ASTHENIA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG CLEARANCE;
DRUG FATALITY;
DRUG HALF LIFE;
DRUG SAFETY;
DRUG TOLERABILITY;
DYSPEPSIA;
FEMALE;
GAIT DISORDER;
HEADACHE;
HUMAN;
INCIDENCE;
LIPID DIET;
MUSCLE CRAMP;
ORAL CONTRACEPTION;
PAIN;
PRURITUS;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
SCORING SYSTEM;
SPOTTING;
UTERINE CERVIX MUCUS;
VAGINA BLEEDING;
VOMITING;
ADULT;
AREA UNDER CURVE;
BENZOXAZINES;
CERVIX MUCUS;
COHORT STUDIES;
CONTRACEPTIVES, ORAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FEMALE;
HALF-LIFE;
HUMANS;
PYRROLES;
RECEPTORS, PROGESTERONE;
|
EID: 33749534497
PISSN: 00107824
EISSN: None
Source Type: Journal
DOI: 10.1016/j.contraception.2006.06.004 Document Type: Article |
Times cited : (7)
|
References (6)
|